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Abstract
The purpose of our study is to investigate
suppression of puberty for transgender teens. We
will examine current treatments, developing
treatments, ethical limitations, and the overarching
questions that cause hesitation in healthcare
providers. Many of the issues faced by these
children stem from their age, and thus their ability
to make rational decisions for themselves. Proposals
against treatment can create psychosocial
developmental issues in teens and increase
developing gender dysphoria; the psychological
distress that results from the inability to align one’s
assigned sex with their new gender identity. But
fears of regretful decision-making leads to the
question of what is more ethical, the postponement
of treatment due to lack of self-awareness or the
alleviation of suffering with the risk of reversal.

For children under the age of 16, most treatments begin with a focus on
psychological components of what it means to be transgender, using specifically
trained individuals, Mental Health Professionals, to diagnose as accurately as possible
the signs and symptoms the child may be experiencing. Likely exploring many facets
of the child’s life; “the etiology of dysphoria will prove to have complex biological,
social, and psychological influences.”
• The Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) states that
the criteria for the diagnosis of gender dysphoria in adolescents and adults as the
presence of a marked incongruence between one’s experienced/expressed
gender and assigned gender, lasting for at least 6 months, as manifested by at
least two of the following: (1) a marked incongruence between one’s
experienced/expressed gender and primary and/or secondary sex characteristics
(or in young adolescents, the anticipated secondary sex characteristics); (2) a
strong desire to be rid of one’s primary and/or secondary sex characteristics
because of a marked incongruence with one’s experienced/expressed gender (or
in young adolescents, a desire to prevent the development of the anticipated
secondary sex characteristics); (3) a strong desire for the primary and/or
secondary sex characteristics of the other gender (or a gender different from that
assigned at birth); (4) a strong desire to be of the other gender (or a gender
different from that assigned at birth); (5) a strong desire to be treated as the other
gender (or a gender different from that assigned at birth); and (6) a strong
conviction that one has the typical feelings and reactions of the other gender (or
a gender different from that assigned at birth). The individual must also
experience clinically significant distress or impairment in social, occupational, or
other important areas of functioning.

This discussion surrounding the suppression of puberty in
transgender teens is important when we consider the
disproportionate number of suicide and mental health
issues in the transgender population. These concerns for
alleviating body dysphoria are valid to consider as some
interventions have the potential to avoid those feelings of
dysphoria before puberty begins. By preventing these
physical, emotional, and hormonal changes to take place, it
may lead to an easier transitioning process for these teens.
However, there are concerns to keep in mind during this
discussion: age of consent, irreversible physical/hormonal
changes, and the potential for a teen’s gender identity to
change later in life. In this discussion, we will evaluate the
scientific changes from these interventions, ethical
concerns, a case study example, and the future implications
of this process.

Introduction

Tanner Stages of Puberty

Secondly the use of continuous gonadotropin-releasing hormone (GnRH) is used in
children typically till the age of 18
• GnRH has the effect of blocking the release of follicle stimulating hormone
(FSH) and luteinizing hormone (LH) from the pituitary gland. These hormones
start the process known as puberty.
• The current recommendation is to start GnRH treatment during “the Tanner II
or III phases” of puberty, so as to halt the puberty before the child feels its
biological effects. This gives the child time to assess their feelings about their
gender identity and sets the stage for them to begin hormone therapy if they
wish to transition to another gender.
• Historically, such treatment has not been readily used in persons under 18. Now
there is strong evidence that waiting this long can increase the chance of children
with a long history of gender dysphoria or GID (gender identity disorder)
developing a psychiatric disorder or having suicidal thoughts.

Then there is sex hormone treatments, which are practically irreversible and requires
sufficient mental capacity to make an informed decision.
• Many scientists and medical professionals are concerned about allowing
adolescents to make lasting decisions about their health and gender when there
has been scientific research showing that during adolescence, the great amount of
neurological development occurring during this time impacts the “processing
rewards and risks, self-regulation, and the effect of peers on decision-making”

Case Studies

Ethics
This section explores the ethical arguments, both for and
against puberty blockers.

For
Non-maleficence and Beneficence (TW//suicide mention)
• A 2020 study by the American Academy of Pediatrics found
treatments for gender dysphoria including puberty suppressing
treatments can be associated with decreased rates of suicidal
ideation and illicit drug use throughout the lifetime of a trans
patient.
• Puberty suppressing hormones allow the decision to commence
HRT to be prolonged allowing patients to mature and develop
their own power of judgement.
• Allowing adolescents to avoid the gendered maturation brought
on by puberty offers the highest likelihood of preferred results
for gender transition later in life.
Respect for patient autonomy
• Despite the fact that minors cannot give legal consent to
treatments does not dismiss the fact that they have a right to
autonomy.
• Seeking gender affirming treatment is a very intimate and
personal decision, puberty suppressors allow kids to not
experience as much gender dysphoria while making those
decisions.
• “[puberty blockers] certainly facilitates exploration significantly
more than letting puberty run its course; whereas puberty
strongly favors cis embodiment by raising the psychological and
medical toll of transitioning”
• A study from the American Academy of Pediatrics found that
only 2.5% of patients with gender dysphoria who wanted
puberty suppressing hormone treatment actually got it.

Against

Informed consent and nonmaleficence
• Early medical transition is irreversible and could lead to sterility later
in life
• Need for more long-term studies to consider the age and
cognitive development of kids with gender dysphoria.
• However, many trans patients report that feeling comfortable
in their own bodies far outweighs the “harm” of losing the
ability to procreate.
• Trans kids are put into a tough position because if they don’t
transition, they can face all kinds of stigma and danger for being
gender non-conforming and not “passing”, but if they do use
medical interventions to transition, they are making an irreversible
decision. Ultimately, as a society, we need to give children the
support and the space, they need to question their gender without
putting pressure on trans people to be “passing”. One way to ensure
this is through the use of psychological treatments for adolescents in
order to allow the child time to mature and evaluate their decision to
ensure that it will be one that affirms their gender identity.

Case Study #1: 18-years-old
Background
• Assigned as female at birth, at the age of 5, Phoenix identified as gender non-binary. At
the age of 11 during the time of puberty, the patient underwent severe distress
regarding pubescent changes and requested puberty blockers. The doctor and patient
agreed to reconvene upon Phoenix turning 16 to further assess treatment options. This
also allowed time for gender identity to solidify.
Diagnosis
• Phoenix does not have any underlying medical conditions. Patient is diagnosed with
gender dysphoria. Doctor has started the current course of treatment and has agreed to
re-evaluate further measures to be taken after 2 years.
Treatment
• Phoenix has been treated with puberty blockers and has requested from her physician to
continue the blockers long term. Patient also has been referred to a psychologist.
Outcome
• Phoenix wants to continue puberty suppressants 'forever’ and has no desire for their
body to change. Patient’s physician is hesitant about the request for long term puberty
suppressants due to physical risks regarding bone health and underlying psychological
risks regarding issues surrounding growing up. Upon psychological evaluations, Phoenix
has decided that the need to remain in a pre-pubescent state is the only way to reflect
the patient’s non-binary identity. Psychologists support Phoenix’s decision to maintain
puberty blockers as the decision was made with consent, free will, and disclosure of
outcomes and potential side effects.

Case Study #2: 10-years-old
Background
• Assigned as female at birth, identifies as male. Questions regarding identity began at
the age of 5 and claims that “he wants to be a boy”. Concerns from the mother
regarding the permanence of some treatments regarding hormones or surgery.
Upon the onset of pubertal changes, patient has experienced severe distress
Diagnosis
• Patient is diagnosed with gender dysphoria which means the gender assigned at
birth is not the same as the gender the patient identifies as which leads to distress.
Treatment
• Transgender teens often have a high rate of suicide, self harm, depression, anxiety,
eating disorders, as well as social conflicts. Care that affirms the gender the patient
identifies with through the use of puberty blockers and/or gender- affirming
hormones can reduce the risk of the previously mentioned illnesses. Puberty
blockers are used for the patient
Outcome
• Patient used puberty blockers. Family also recognizes the severity of distress the
patient must feel which allows them to seek out a mental health provider. Pursuing
treatment has improved family relations and decreased some stress on the
patient. Patient feels confident in their decision and engages in therapy and hopes
to begin testosterone at the age of 14.
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